Role of Beta Blockers in Managing Variceal Bleeding in Children

Mechanism of Action

Non-selective beta blockers reduce portal pressure through two mechanisms: decreasing cardiac output via β1-receptor blockade and producing splanchnic vasoconstriction through β2-receptor blockade, leading to decreased portal venous inflow and lower portal pressure, with a target reduction of 20% in portal pressure gradient 1, 2
Selective beta blockers are less effective and suboptimal for variceal hemorrhage prophylaxis 3

Non-selective beta blockers are recommended for children with small varices who have high bleeding risk, with propranolol being effective for preventing first variceal bleeding, particularly in patients with certain liver function classifications 3, 4
The risk of first variceal bleeding is significantly reduced with beta blockers, from 30% to 14% in patients with medium/large varices, with one bleeding episode avoided for every 10 patients treated with beta blockers 5

Combination therapy with non-selective beta blockers plus endoscopic variceal ligation is superior to endoscopic variceal ligation alone for preventing rebleeding 2

The dose of propranolol should be titrated to the maximum tolerated dose rather than targeting heart rate reduction, as heart rate reduction does not correlate with hepatic venous pressure gradient reduction 3
Once started, beta blocker therapy should be continued indefinitely unless contraindications develop 3, 2

Beta blockers should not be used during acute variceal bleeding episodes as they decrease blood pressure and blunt the physiologic increase in heart rate associated with bleeding 2
Contraindications include hypotension, severe bradycardia, high-degree heart block, and asthma 2
Adverse events are more common with beta blockers compared to placebo 4
Beta blockers should be started for secondary prophylaxis once the patient has recovered from the acute bleeding episode and before discharge from hospital 2

In patients with small varices receiving beta blockers, follow-up endoscopy may not be necessary, while those not receiving beta blockers should have endoscopy repeated every 2 years, or annually if there is evidence of hepatic decompensation 3
The lowest rebleeding rate is observed in patients who are "hepatic venous pressure gradient responders" 6, 2